Citations

Clear

750 citation(s) found for "Lowe, Val".

Diffusivity Changes in Posterior Cortical Atrophy and Logopenic Progressive Aphasia: A Longitudinal Diffusion Tensor Imaging Study
Singh, Neha Atulkumar , Graff‐Radford, Jonathan , Pham, Nha Trang Thu, Lowe, Val J. , Petersen, Ronald C. , Josephs, Keith A. , Whitwell, Jennifer L. , Singh, Neha Atulkumar , Machulda, Mary M. , Schwarz, Christopher G. , Reid, Robert I. , Jack, Clifford R.

Mayo Clinic

Journal of Alzheimer's Disease | June 9, 2023 | Volume: 94 | Issue: 2 | Pages: 709-725

10.3233/jad-221217 | PMID 37302032 Get It

Background: Posterior cortical atrophy (PCA) and logopenic progressive aphasia (LPA) are associated with characteristic patterns of structural network degeneration. Little is known about longitudinal patterns of white matter tract degeneration in these phenotypes. Objective: To assess longitudinal patterns of white matter degeneration and identify phenotype specific cross-sectional and longitudinal diffusion tensor imaging (DTI) biomarkers in PCA and LPA. Methods: Twenty-five PCA, 22 LPA and 25 cognitively unimpaired (CU) individuals were recruited and underwent structural MRI that included a DTI sequence with a follow-up one year later. Cross-sectional and longitudinal mixed effects models were fit to assess the effects of diagnosis on baseline and annualized change in regional DTI metrics. Discriminatory power was investigated using the area under the receiver operating characteristic curves (AUROC). Results: PCA and LPA showed overlapping white matter degeneration profiles predominantly in the left occipital and temporal lobes, the posterior thalamic radiation and sagittal stratum at baseline, as well as the parietal lobe longitudinally. PCA showed degeneration in the occipital and parietal white matter, cross-sectionally and longitudinally, compared to CU, while LPA showed greater degeneration in the temporal and inferior parietal white matter and the inferior fronto-occipital fasciculus cross-sectionally, and in parietal white matter longitudinally compared to CU. Cross-sectionally, integrity of the inferior occipital white matter was best able to differentiate PCA from LPA, with an AUROC of 0.82. Conclusion: These findings contribute to our understanding of white matter degeneration and support usage of DTI as a useful additional diagnostic biomarker for PCA and LPA.
Genetic risk scores enhance the diagnostic value of plasma biomarkers of brain amyloidosis
Ramanan, Vijay K. , Gebre, Robel K , Graff‐Radford, Jonathan , Hofrenning, Ekaterina I. , Figdore, Daniel J. , Lowe, Val J. , Knopman, David S. , Ross, Owen A. , Jack, Clifford R. , Petersen, Ronald C. , Vemuri, Prashanthi , Knopman, David S. , Hofrenning, Ekaterina, Jack, Clifford R , Vemuri, Prashanthi , Ross, Owen A , Ramanan, Vijay K , Figdore, Daniel J , Algeciras‐Schimnich, Alicia , Mielke, Michelle M.

Mayo Clinic

Brain | June 3, 2023 | Volume: 146 | Issue: 11 | Pages: 4508-4519

10.1093/brain/awad196 | PMID 37279785 Get It

Abstract Blood-based biomarkers offer strong potential to revolutionize diagnosis, trial enrolment and treatment monitoring in Alzheimer’s disease (AD). However, further advances are needed before these biomarkers can achieve wider deployment beyond selective research studies and specialty memory clinics, including the development of frameworks for optimal interpretation of biomarker profiles. We hypothesized that integrating Alzheimer’s disease genetic risk score (AD-GRS) data would enhance the diagnostic value of plasma AD biomarkers by better capturing extant disease heterogeneity. Analysing 962 individuals from a population-based sample, we observed that an AD-GRS was independently associated with amyloid PET levels (an early marker of AD pathophysiology) over and above APOE ε4 or plasma p-tau181, amyloid-β42/40, glial fibrillary acidic protein or neurofilament light chain. Among individuals with a high or moderately high plasma p-tau181, integrating AD-GRS data significantly improved classification accuracy of amyloid PET positivity, including the finding that the combination of a high AD-GRS and high plasma p-tau181 outperformed p-tau181 alone in classifying amyloid PET positivity (88% versus 68%; P = 0.001). A machine learning approach incorporating plasma biomarkers, demographics and the AD-GRS was highly accurate in predicting amyloid PET levels (90% training set; 89% test set) and Shapley value analyses (an explainer method based in cooperative game theory) indicated that the AD-GRS and plasma biomarkers had differential importance in explaining amyloid deposition across individuals. Polygenic risk for AD dementia appears to account for a unique portion of disease heterogeneity, which could non-invasively enhance the interpretation of blood-based AD biomarker profiles in the population.
Frontotemporal Hypometabolism in Medication-Induced Tardive Dyskinesia
Liu, Tina , Benarroch, Eduardo E. , Hogan, William J. , Lowe, Val J. , Savica, Rodolfo , Hogan, William J , Savica, Rodolfo , McKeon, Andrew

Mayo Clinic

Neurology | May 18, 2023 | Volume: 101 | Issue: 13 | Pages: 585-587

10.1212/wnl.0000000000207439 | PMID 37202164 Get It

Semantic Variant Primary Progressive Aphasia Associated with the C9orf72 Hexanucleotide Expansion – A Longitudinal Case Report (P13-6.004)
Switzer, Aaron , Fields, Julie A. , Kantarci, Kejal , Lowe, Val J. , Gavrilova, Ralitza H. , Forsberg, Leah K. , Nelson, Kevin L., Kolander, Tyler, Kantarci, Kejal , Switzer, Aaron R , Corriveau‐Lecavalier, Nick , Jones, David T. , Botha, Hugo , Knopman, David S. , Ramanan, Vijay K. , Lapid, Maria I. , Nelson, Kevin, Boeve, Bradley F.

Mayo Clinic

Neurology | April 28, 2023 | Volume: 100 | Issue: 17_supplement_2 | Pages: No page available

10.1212/wnl.0000000000203291 Get It

Primary progressive apraxia of speech: Clinico-pathological associations of left-right hemispheric dominance (S8.008)
Robinson, Carling G. , Utianski, Rene, Singh, Neha Atulkumar , Pham, Nha Trang Thu, Martin, Peter, Ertekin‐Taner, Nilüfer , Lowe, Val J. , Whitwell, Jennifer L. , Josephs, Keith A. , Singh, Neha Atulkumar , Duffy, Joseph R. , Clark, Heather M. , Machulda, Mary M. , Botha, Hugo , Martin, Peter, Dickson, Dennis W.

Mayo Clinic

Neurology | April 28, 2023 | Volume: 100 | Issue: 17_supplement_2 | Pages: No page available

10.1212/wnl.0000000000202410 Get It

Decline in Visual and Posterior Cortical Functions in Logopenic Progressive Aphasia (P5-6.001)
Graff‐Radford, Jonathan , Lowe, Val J. , Josephs, Keith A. , Whitwell, Jennifer L. , Singh, Neha Atulkumar , Carlos, Arenn F. , Machulda, Mary M. , Schwarz, Christopher G. , Senjem, Matthew L. , Jack, Clifford R. , Whitwell, Jennifer L.

Mayo Clinic

Neurology | April 28, 2023 | Volume: 100 | Issue: 17_supplement_2 | Pages: No page available

10.1212/wnl.0000000000201840 Get It

Clinicopathological associations of hemispheric dominance in primary progressive apraxia of speech
Robinson, Carling G. , Utianski, Rene L. , Singh, Neha Atulkumar , Pham, Nha Trang Thu, Ertekin‐Taner, Nilüfer , Lowe, Val J. , Whitwell, Jennifer L. , Josephs, Keith A. , Clark, Heather A, Utianski, Rene L , Singh, Neha Atulkumar , Whitwell, Jennifer , Josephs, Keith A , Duffy, Joseph R. , Clark, Heather A., Machulda, Mary M. , Botha, Hugo , Dickson, Dennis W.

Mayo Clinic

European Journal of Neurology | March 4, 2023 | Volume: 30 | Issue: 5 | Pages: 1209-1219

10.1111/ene.15764 | PMID 36869612 Get It

AbstractObjectivePrimary progressive apraxia of speech (PPAOS) is associated with imaging abnormalities in the lateral premotor cortex (LPC) and supplementary motor area (SMA). It is not known whether greater involvement of these regions in either hemisphere is associated with demographics, presenting, and/or longitudinal features.MethodsIn 51 prospectively recruited PPAOS patients who completed [18F]‐fluorodeoxyglucose (FDG) positron emission tomography (PET), we classified patients as left‐dominant, right‐dominant, or symmetric, based on visual assessment of the LPC and SMA on FDG‐PET. SPM and statistical analyses of regional metabolic values were performed. Diagnosis of PPAOS was made if apraxia of speech was present and aphasia absent. Thirteen patients completed ioflupane‐123I (dopamine transporter [DAT]) scans. We compared cross‐sectional and longitudinal clinicopathological, genetic, and neuroimaging characteristics across the three groups, with area under the receiver‐operating curve (AUROC) determined as a measure of effect size.ResultsIn all, 49% of the PPAOS patients were classified as left‐dominant, 31% as right‐dominant, and 20% as symmetric, which was supported by results from the SPM and regional analyses. There were no differences in baseline characteristics. Longitudinally, right‐dominant PPAOS showed faster rates of progression of ideomotor apraxia (AUROC 0.79), behavioral disturbances (AUROC 0.84), including disinhibition symptoms (AUROC 0.82) and negative behaviors (AUROC 0.82), and parkinsonism (AUROC 0.75) compared to left‐dominant PPAOS. Symmetric PPAOS showed faster rates of dysarthria progression compared to left‐dominant (AUROC 0.89) and right‐dominant PPAOS (AUROC 0.79). Five patients showed abnormal DAT uptake. Braak neurofibrillary tangle stage differed across groups (p = 0.01).ConclusionsPatients with PPAOS and a right‐dominant pattern of hypometabolism on FDG‐PET have the fastest rates of decline of behavioral and motor features.